| HGNC Family | Non-coding RNAs |
| Name | microRNA 139 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR-139 – encompassing both its ‑5p and ‑3p isoforms – is emerging as a potent tumor suppressor whose expression is frequently down‐regulated across a wide spectrum of human malignancies, including hepatocellular, colorectal, breast, esophageal, bladder, gallbladder, cervical, prostate, oral, laryngeal, and glioblastoma cancers. In these settings, restoration of miR-139 levels has been shown to inhibit cell proliferation, migration, invasion, metastasis, and the epithelial–mesenchymal transition through direct targeting of multiple oncogenes – such as IGF1R, MMP11, ETS1, BCL2, c-Fos, ZEB1/ZEB2, NR5A2, NOB1, CXCR4, HOXA9, and others – thereby interfering with aberrant Ras, Wnt/β-catenin, TGF-β, and PI3K/AKT signaling cascades. Importantly, re-expression of miR-139 not only reverses aggressive cancer phenotypes but also enhances sensitivity to chemotherapeutics and radiotherapy, underscoring its promise as both a prognostic biomarker and a therapeutic target."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "37"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its oncologic roles, miR-139 holds significant diagnostic and functional importance in non-malignant contexts. For instance, elevated exosomal miR-139-5p levels have been implicated in major depressive disorder, where they impair neurogenesis by reducing neural stem cell proliferation and differentiation. In parallel, modulation of miR-139-5p influences skeletal biology: its inhibition in bone marrow-derived mesenchymal stem cells promotes osteogenic differentiation, while altered miR-139 expression in osteoarthritis chondrocytes perturbs inflammatory signaling, notably by affecting IL-6 levels. These findings collectively highlight the potential of miR-139 as a biomarker for early disease detection and prognostication in diverse pathophysiologic settings."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "38", "end_ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the mechanistic level, miR-139 exerts its regulatory influence by binding directly to the 3′ untranslated regions of target mRNAs, thereby promoting transcript degradation or translational repression. Its own expression is subject to multilayered regulation—epigenetic modifiers such as EZH2 can silence the miR-139 promoter via H3K27 trimethylation, and long noncoding RNAs like XIST and NEAT1 act as molecular sponges that sequester miR-139, effectively derepressing oncogenic targets. Reciprocal feedback interactions with key transcription factors, including TCF-4, further embed miR-139 within signaling networks governing cell survival, metabolism, and the epithelial–mesenchymal transition. These interconnected regulatory circuits not only shed light on the diverse functional roles of miR-139 but also underscore the therapeutic promise of strategies aimed at restoring its expression to counteract tumor progression and treatment resistance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}, {"type": "fg_f", "ref": "23"}, {"type": "fg_f", "ref": "29"}, {"type": "fg_f", "ref": "32"}, {"type": "fg_f", "ref": "37"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Carmen Chak-Lui Wong, Chun-Ming Wong, Edmund Kwok-Kwun Tung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2010.10.006"}], "href": "https://doi.org/10.1053/j.gastro.2010.10.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20951699"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20951699"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "K J Schmitz, J Helwig, S Bertram, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Pathol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jcp.2010.085621"}], "href": "https://doi.org/10.1136/jcp.2010.085621"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21471143"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21471143"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Wei Bao, Hai-Jing Fu, Qiao-Sheng Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2011.08.050"}], "href": "https://doi.org/10.1053/j.gastro.2011.08.050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21925125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21925125"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Gregory D Miles, Michael Seiler, Lorna Rodriguez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identifying microRNA/mRNA dysregulations in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Res Notes (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1756-0500-5-164"}], "href": "https://doi.org/10.1186/1756-0500-5-164"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22452920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22452920"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Haiyan Guo, Xiaobo Hu, Shengfang Ge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biocel.2012.05.015"}], "href": "https://doi.org/10.1016/j.biocel.2012.05.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22642900"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22642900"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Qin Fan, Minyi He, Xinjun Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biochem Funct (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbf.2902"}], "href": "https://doi.org/10.1002/cbf.2902"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23001723"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23001723"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Miao Yang, Ran Liu, Jingyi Sheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2012.2105"}], "href": "https://doi.org/10.3892/or.2012.2105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23124769"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23124769"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Ran Liu, Miao Yang, Yanli Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor-suppressive function of miR-139-5p in esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0077068"}], "href": "https://doi.org/10.1371/journal.pone.0077068"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24204738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24204738"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Hua-Nan Luo, Zheng-Hui Wang, Ying Sheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-013-0789-z"}], "href": "https://doi.org/10.1007/s12032-013-0789-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24318902"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24318902"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Lijing Zhang, Yujuan Dong, Nana Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1476-4598-13-124"}], "href": "https://doi.org/10.1186/1476-4598-13-124"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24885920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24885920"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ke Shen, Rurong Mao, Li Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Post-transcriptional regulation of the tumor suppressor miR-139-5p and a network of miR-139-5p-mediated mRNA interactions in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.12880"}], "href": "https://doi.org/10.1111/febs.12880"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24942287"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24942287"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Mingxu Song, Yuan Yin, Jiwei Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Protein Cell (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13238-014-0093-5"}], "href": "https://doi.org/10.1007/s13238-014-0093-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25149074"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25149074"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Xiaojing Liu, Bensong Duan, Yuanyuan Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-139-3p indicates a poor prognosis of colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2014)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25550849"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25550849"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "He-da Zhang, Lin-hong Jiang, Da-wei Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-139-5p: promising biomarker for cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-3199-3"}], "href": "https://doi.org/10.1007/s13277-015-3199-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25691250"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25691250"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Iane O P Porto, Celso T Mendes-Junior, Leandro P Felício, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNAs targeting the immunomodulatory HLA-G gene: a new survey searching for microRNAs with potential to regulate HLA-G."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Immunol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molimm.2015.01.030"}], "href": "https://doi.org/10.1016/j.molimm.2015.01.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25700346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25700346"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Gongcai Qiu, Yujia Lin, Haogang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.05.062"}], "href": "https://doi.org/10.1016/j.bbrc.2015.05.062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26022123"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26022123"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Wei Xu, Meng Hang, Chen-Ye Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26097570"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26097570"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "S Emmrich, F Engeland, M El-Khatib, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-139-5p controls translation in myeloid leukemia through EIF4G2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2015.247"}], "href": "https://doi.org/10.1038/onc.2015.247"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26165837"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26165837"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "He-da Zhang, Da-Wei Sun, Ling Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.08.053"}], "href": "https://doi.org/10.1016/j.bbrc.2015.08.053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26299922"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26299922"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Mehmet Bugrahan Duz, Omer Faruk Karatas, Esra Guzel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Oncol (Dordr) (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13402-015-0259-z"}], "href": "https://doi.org/10.1007/s13402-015-0259-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26650483"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26650483"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Masaya Yonemori, Naohiko Seki, Hirofumi Yoshino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.13002"}], "href": "https://doi.org/10.1111/cas.13002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27355528"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27355528"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Ping Huang, Jie Xi, Shikai Liu "}, {"type": "b", "children": [{"type": "t", "text": "MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2016.07.050"}], "href": "https://doi.org/10.1016/j.biopha.2016.07.050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27505862"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27505862"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yichao Mo, Yaoyong Lu, Peng Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA XIST promotes cell growth by regulating miR-139-5p/PDK1/AKT axis in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317690999"}], "href": "https://doi.org/10.1177/1010428317690999"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28231734"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28231734"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Lui Ng, Timothy Ming-Hun Wan, Johnny Hon-Wai Man, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.16171"}], "href": "https://doi.org/10.18632/oncotarget.16171"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28404964"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28404964"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Kai Wang, Jun Jin, Tengxiao Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.13282"}], "href": "https://doi.org/10.1111/jcmm.13282"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28780773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28780773"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Marina Pajic, Danielle Froio, Sheridan Daly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-16-3105"}], "href": "https://doi.org/10.1158/0008-5472.CAN-16-3105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29180477"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29180477"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Shengni Hua, Ling Lei, Ling Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-017-0057-3"}], "href": "https://doi.org/10.1038/s41388-017-0057-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29335523"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29335523"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Claire Agosta, Jonathan Laugier, Laurent Guyon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.31363"}], "href": "https://doi.org/10.1002/ijc.31363"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29516499"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29516499"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Jianfei Tu, Zhongwei Zhao, Min Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.26524"}], "href": "https://doi.org/10.1002/jcp.26524"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29797561"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29797561"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Jianan Chen, Yan Yu, Xiaolong Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Prolif (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cpr.12510"}], "href": "https://doi.org/10.1111/cpr.12510"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30105813"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30105813"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jianlong Li, Qingbin Li, Lin Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Neurol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12883-018-1139-8"}], "href": "https://doi.org/10.1186/s12883-018-1139-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30170559"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30170559"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Jin Ma, Jun Zhang, Yuan-Chi Weng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cells (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14348/molcells.2018.0109"}], "href": "https://doi.org/10.14348/molcells.2018.0109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30304920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30304920"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Bin Yang, Wenyu Zhang, Daju Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.09.029"}], "href": "https://doi.org/10.1016/j.biopha.2018.09.029"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30551470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30551470"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Peng Li, Zhiwei Xiao, Jiajun Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.14121"}], "href": "https://doi.org/10.1111/jcmm.14121"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30710422"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30710422"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Guifang Xu, Bin Zhang, Jiahui Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.33750"}], "href": "https://doi.org/10.7150/ijbs.33750"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31595150"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31595150"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Jin-Hui Zhu, Ramon Andrade De Mello, Qiu-Liang Yan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta Mol Basis Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbadis.2020.165747"}], "href": "https://doi.org/10.1016/j.bbadis.2020.165747"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32109492"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32109492"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Feng Du, Tianyu Cao, Huahong Xie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "KRAS Mutation-Responsive miR-139-5p inhibits Colorectal Cancer Progression and is repressed by Wnt Signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.45971"}], "href": "https://doi.org/10.7150/thno.45971"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32641995"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32641995"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Mohammad Shahidul Makki, Tariq M Haqqi "}, {"type": "b", "children": [{"type": "t", "text": "miR-139 modulates MCPIP1/IL-6 expression and induces apoptosis in human OA chondrocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Mol Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/emm.2015.66"}], "href": "https://doi.org/10.1038/emm.2015.66"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26450708"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26450708"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Weihua Hu, Weikai Zhang, Feng Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-139 is up-regulated in osteoarthritis and inhibits chondrocyte proliferation and migration possibly via suppressing EIF4G2 and IGF1R."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2016.03.164"}], "href": "https://doi.org/10.1016/j.bbrc.2016.03.164"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27105918"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27105918"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Haitao Long, Buhua Sun, Liang Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-139-5p Represses BMSC Osteogenesis via Targeting Wnt/β-Catenin Signaling Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Cell Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/dna.2017.3657"}], "href": "https://doi.org/10.1089/dna.2017.3657"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28622009"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28622009"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Ze-Xu Wei, Guo-Jun Xie, Xiao Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomes from patients with major depression cause depressive-like behaviors in mice with involvement of miR-139-5p-regulated neurogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41386-020-0622-2"}], "href": "https://doi.org/10.1038/s41386-020-0622-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31986519"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31986519"}]}]}]}
|
| Synonyms | MIR139-3P, MIRN139, MIR-139 |
| NCBI Gene ID | 406931 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR139 has 496 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 22 datasets.
Click the + buttons to view associations for MIR139 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR139 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR139 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR139 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR139 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR139 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR139 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR139 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR139 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing MIR139 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with MIR139 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR139 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR139 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR139 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR139 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MIR139 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR139 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR139 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR139 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MIR139 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR139 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MIR139 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR139 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |